Charcot-Marie-Tooth type 1A drug therapies: role of adenylyl cyclase activity and G-protein coupled receptors in disease pathomechanism
2018 ◽
Vol 78
(3)
◽
pp. 198-209
◽
2000 ◽
Vol 95
(1-3)
◽
pp. 53-58
◽
1997 ◽
Vol 273
(6)
◽
pp. F883-F891
◽
1993 ◽
Vol 101
(5)
◽
pp. 646-651
◽
2002 ◽
Vol 70
(6)
◽
pp. 2620-2627
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
1992 ◽
Vol 70
(1)
◽
pp. 77-84
◽